NCT00092976View on ClinicalTrials.gov

Study Evaluating ReFacto® in Hemophilia A Undergoing Major Surgery

PHASE4CompletedINTERVENTIONAL
Enrollment

15

Participants

Timeline

Start Date

February 28, 2003

Study Completion Date

July 31, 2007

Conditions
Hemophilia A
Interventions
DRUG

ReFacto

Trial Locations (4)

17033

Hershey

45229

Cincinnati

90007

Los Angeles

08903-0019

New Brunswick

All Listed Sponsors
lead

Wyeth is now a wholly owned subsidiary of Pfizer

INDUSTRY

NCT00092976 - Study Evaluating ReFacto® in Hemophilia A Undergoing Major Surgery | Biotech Hunter | Biotech Hunter